Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹82546 Cr.
Stock P/E
90.1
P/B
5
Current Price
₹627.6
Book Value
₹ 126.2
Face Value
2
52W High
₹813.7
52W Low
₹ 625.9
Dividend Yield
0%

Manipal Health Enter Overview

Business

Manipal Health Enterprises Ltd. (MHE) is one of India's leading multi-specialty healthcare providers. The company operates a chain of hospitals, offering comprehensive medical services across various specialties including cardiology, oncology, orthopedics, neurology, gastroenterology, and more. Its core business model involves generating revenue through patient fees for consultations, diagnostic services, surgical procedures, inpatient stays, pharmacy sales, and specialized treatments. Manipal Health focuses on providing accessible, high-quality, and affordable tertiary and quaternary healthcare.

Revenue Mix

While specific revenue percentages are not publicly detailed for this overview, MHE's revenue is primarily derived from:

In-patient services: This constitutes the largest portion, including income from patient admissions, surgeries, procedures, ICU stays, and room charges.

Out-patient services: Revenue from consultations, minor procedures, diagnostic tests (pathology, radiology), and follow-up visits.

Pharmacy sales: Revenue from dispensing medicines to both inpatients and outpatients.

Other services: Includes revenue from specialized clinics, health check-ups, and potentially medical tourism.

Industry

The Indian hospital and healthcare services industry is characterized by strong growth, driven by a large and aging population, rising disposable incomes, increasing health awareness, lifestyle diseases, and improving insurance penetration. The sector is fragmented, with a mix of large corporate chains, regional players, and standalone hospitals. Manipal Health Enterprises is positioned as one of the largest and most prominent multi-specialty hospital chains in India, with a significant presence particularly in South India and a growing footprint across other regions. It holds a strong brand reputation, often associated with its legacy in medical education.

MOAT

Brand Reputation: A strong and established brand name, rooted in the Manipal Education & Medical Group's legacy of quality healthcare and education, fosters trust and patient loyalty.

Scale & Network: A wide network of multi-specialty hospitals across India provides economies of scale in procurement, talent acquisition, and operational efficiencies.

Clinical Excellence & Talent: Ability to attract and retain highly skilled medical professionals and specialists due to its reputation, infrastructure, and referral network, ensuring high standards of clinical outcomes.

Patient Switching Costs: For complex or chronic conditions, patients often face high implicit switching costs once a relationship with doctors and a hospital system is established, due to continuity of care and trust.

Growth Drivers

Increasing Healthcare Expenditure: Rising GDP per capita, higher disposable incomes, and greater health insurance coverage are boosting demand for quality healthcare.

Demographic Trends: India's large and growing population, coupled with an increasing burden of chronic and lifestyle diseases, ensures a sustained demand for hospital services.

Expansion & Acquisitions: The company's strategy of organic (greenfield/brownfield) and inorganic (acquisitions of smaller hospitals or chains) expansion to new geographies and consolidating market share.

Medical Tourism: India's position as a hub for affordable and high-quality medical treatment attracts international patients, benefiting large hospital chains like Manipal.

Digital Health Adoption: Leverage of technology such as telemedicine, AI-driven diagnostics, and digital patient management systems to improve efficiency and reach.

Risks

Regulatory & Policy Risks: Government intervention in pricing of procedures, drugs, or medical devices, as well as evolving healthcare policies, can impact profitability.

Intense Competition: The sector faces strong competition from other large corporate hospital chains, regional players, and new entrants, potentially leading to pricing pressures.

Manpower Shortages & Costs: A shortage of skilled doctors, nurses, and paramedical staff, along with rising salary expectations, can increase operational costs.

High Capital Expenditure: The hospital business is highly capital-intensive, requiring continuous investment in infrastructure, medical equipment, and technology.

Medico-Legal & Ethical Risks: Hospitals are exposed to risks of malpractice suits, reputational damage from adverse events, and ethical scrutiny.

Economic Downturns: Recessions or significant economic slowdowns can reduce elective procedures and patient spending on healthcare.

Management & Ownership

Manipal Health Enterprises is promoted by the Manipal Education & Medical Group (MEMG), a conglomerate with a rich heritage in education and healthcare. The company is professionally managed with a blend of experienced healthcare administrators and medical professionals. The promoter group maintains significant control, providing strategic direction and leveraging the group's extensive network and expertise in the healthcare ecosystem.

Outlook

Manipal Health Enterprises is well-positioned to capitalize on the robust growth trajectory of the Indian healthcare sector, driven by strong underlying demand and increasing healthcare expenditure. Its established brand, extensive network, and focus on clinical excellence provide a solid foundation for future expansion, both organically and through strategic acquisitions. However, the company operates in a highly regulated and competitive environment. Sustaining growth will require effective navigation of potential regulatory headwinds, careful cost management, successful integration of new assets, and continued investment in technology and talent. Its ability to balance expansion with profitability, while maintaining quality standards, will be key to its long-term performance.

Manipal Health Enter Share Price

Live · BSE / NSE · Inception: 2010
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Manipal Health Enter Quarterly Results

#(Fig in Cr.) Jun 2025 Jun 2026
Net Sales 2238 3091
Other Income 48 75
Total Income 2286 3165
Total Expenditure 1651 2354
Operating Profit 635 811
Interest 132 293
Depreciation 141 187
Exceptional Income / Expenses -18 -15
Profit Before Tax 344 315
Provision for Tax 90 72
Profit After Tax 254 243
Adjustments -4 -12
Profit After Adjustments 250 232
Adjusted Earnings Per Share 2.2 2

Manipal Health Enter Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 1260 1398 1567 1794 2025 1813 3975 4806 6172 8242 10336 5329
Other Income 53 47 39 29 35 58 109 88 97 157 185 123
Total Income 1313 1444 1605 1823 2060 1871 4084 4894 6269 8400 10521 5451
Total Expenditure 1106 1204 1335 1528 1622 1483 3076 3562 4492 6153 7725 4005
Operating Profit 207 240 270 295 438 388 1009 1332 1777 2247 2796 1446
Interest 99 155 170 180 211 205 326 329 455 512 864 425
Depreciation 100 134 163 213 175 183 256 315 397 507 680 328
Exceptional Income / Expenses -7 -10 -31 -12 58 -85 210 -102 -180 14 -74 -33
Profit Before Tax 1 -59 -94 -109 110 -86 637 586 745 1242 1178 659
Provision for Tax 28 -19 -12 26 46 32 90 157 212 161 262 162
Profit After Tax -27 -40 -82 -135 64 -117 547 429 533 1082 917 497
Adjustments -4 0 3 -1 -8 -18 -5 -2 61 -16 -24 -16
Profit After Adjustments -31 -40 -79 -136 56 -136 542 427 594 1065 892 482
Adjusted Earnings Per Share -0.3 -0.4 -0.8 -1.3 0.5 -1.3 4.8 3.8 5.2 46.1 7.6 4.2

Manipal Health Enter Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 1412 1387 1335 1203 1270 1132 2808 3242 4016 5847 8426
Minority's Interest 14 14 11 12 111 99 100 124 72 153 373
Borrowings 1010 1275 1585 1647 1708 1451 1604 1948 3700 4470 9949
Other Non-Current Liabilities 95 83 93 106 447 473 1095 1235 1313 1626 2625
Total Current Liabilities 331 315 441 545 641 869 1739 1214 1657 1795 3362
Total Liabilities 2863 3074 3465 3511 4177 4024 7346 7763 10757 13890 24735
Fixed Assets 1658 2104 2531 2558 3071 2239 4484 4742 8158 9826 18753
Other Non-Current Assets 570 281 338 368 428 657 1502 1426 541 1210 1873
Total Current Assets 634 689 596 586 678 716 1353 1588 2051 2848 4102
Total Assets 2863 3074 3465 3511 4177 4024 7346 7763 10757 13890 24735

Manipal Health Enter Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents -13 -10 -5 27 73 64 22 57 68 361 291
Cash Flow from Operating Activities 67 110 408 270 409 426 805 1149 1389 1570 2078
Cash Flow from Investing Activities -169 -227 -544 -127 -324 -188 -1711 -994 -870 -2658 -7037
Cash Flow from Financing Activities 106 150 168 -104 -93 -280 941 -144 -250 904 4954
Net Cash Inflow / Outflow 3 32 32 40 -8 -42 34 12 268 -184 -4
Closing Cash & Cash Equivalent -10 22 27 67 64 22 57 68 361 291 299

Manipal Health Enter Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) -0.34 -0.39 -0.77 -1.32 0.54 -1.32 4.78 3.77 5.24 46.08 7.56
CEPS(Rs) 0.81 0.91 0.79 0.76 2.31 0.64 7.08 6.56 8.2 68.71 13.53
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 15.52 13.39 12.89 11.6 12.22 10.99 24.59 28.38 35.38 251.17 70.8
Core EBITDA Margin(%) 12.2 13.83 14.76 14.84 19.9 18.21 22.63 25.89 27.21 25.35 25.26
EBIT Margin(%) 7.94 6.82 4.86 3.92 15.88 6.58 24.22 19.04 19.44 21.28 19.76
Pre Tax Margin(%) 0.07 -4.24 -6.02 -6.09 5.44 -4.72 16.03 12.18 12.07 15.07 11.4
PAT Margin (%) -2.15 -2.89 -5.25 -7.52 3.15 -6.47 13.75 8.93 8.64 13.12 8.87
Cash Profit Margin (%) 5.83 6.73 5.17 4.34 11.78 3.63 20.19 15.49 15.07 19.27 15.44
ROA(%) -1.13 -1.36 -2.52 -3.87 1.66 -2.86 9.62 5.68 5.76 8.78 4.75
ROE(%) -2.31 -2.9 -6.08 -10.69 5.2 -9.81 27.88 14.28 14.74 22.03 12.95
ROCE(%) 4.74 3.63 2.67 2.38 10.69 4.13 25.71 17.99 17.98 18.89 13.93
Receivable days 27.76 31.63 31.12 30.29 27.26 27.73 19.69 23.06 22.72 24.27 27.67
Inventory Days 9.39 10.05 8.96 7.8 7.48 6.57 4.6 5.33 4.92 5.21 5.33
Payable days 99.48 130.71 176.49 225.78 263.98 332.52 200.58 264.73 276.71 245.19 223.46
PER(x) 0 0 0 0 0 0 0 0 0 0 0
Price/Book(x) 0 0 0 0 0 0 0 0 0 0 0
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.9 0.99 1.07 0.96 0.89 0.89 0.47 0.43 0.59 0.55 0.99
EV/Core EBITDA(x) 5.47 5.76 6.2 5.86 4.13 4.18 1.87 1.55 2.05 2.01 3.65
Net Sales Growth(%) 22.63 10.95 12.08 14.54 12.83 -10.44 119.23 20.9 28.42 33.55 25.4
EBIT Growth(%) 213.68 -4.71 -20.16 -7.47 356.82 -62.87 706.53 -4.96 31.14 46.19 16.43
PAT Growth(%) -62.02 -49.32 -103.39 -63.94 147.36 -283.73 565.87 -21.52 24.28 102.86 -15.27
EPS Growth(%) -60.13 -14 -98.13 -71.13 141.07 -343.7 462.57 -21.14 39.08 779.64 -83.59
Debt/Equity(x) 0.79 0.97 1.24 1.45 1.43 1.39 0.71 0.67 0.98 0.82 1.23
Current Ratio(x) 1.91 2.19 1.35 1.08 1.06 0.82 0.78 1.31 1.24 1.59 1.22
Quick Ratio(x) 1.8 2.06 1.27 1 0.99 0.8 0.73 1.26 1.18 1.51 1.17
Interest Cover(x) 1.01 0.62 0.45 0.39 1.52 0.58 2.96 2.78 2.64 3.43 2.36
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +25% +29% +42% +23%
Operating Profit CAGR +24% +28% +48% +30%
PAT CAGR -15% +29% — —
Share Price CAGR — — — —
ROE Average +13% +17% +18% +6%
ROCE Average +14% +17% +19% +11%

Manipal Health Enter Shareholding Pattern

Latest · Aug 2026
100% held
Promoters 72.08 %
FII 3.65 %
DII (MF + Insurance) 5.46 %
Public (retail) 18.81 %
# Jun 2026 Aug 2026
Promoter 072.08
FII 03.65
DII 05.46
Public 018.81
Others 00
Total 100100

Manipal Health Enter Peer Comparison

Hospital & Healthcare Services Edit Columns

Manipal Health Enter Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Manipal Health Enter Pros & Cons

Pros

  • Debtor days have improved from 245.19 to 223.46days.

Cons

    0
  • Stock is trading at 5 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp